Anti-S39AB/ SLC39A11/ C17orf26 monoclonal antibody
Anti-S39AB/ SLC39A11/ C17orf26 antibody for FACS & in-vivo assay
Go to SLC39A11/SLC39A11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1614-Ab-1/ GM-Tg-hg-MP1614-Ab-2 | Anti-Human SLC39A11 monoclonal antibody | Human |
GM-Tg-rg-MP1614-Ab-1/ GM-Tg-rg-MP1614-Ab-2 | Anti-Rat SLC39A11 monoclonal antibody | Rat |
GM-Tg-mg-MP1614-Ab-1/ GM-Tg-mg-MP1614-Ab-2 | Anti-Mouse SLC39A11 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1614-Ab-1/ GM-Tg-cynog-MP1614-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLC39A11 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1614-Ab-1/ GM-Tg-felg-MP1614-Ab-2 | Anti-Feline SLC39A11 monoclonal antibody | Feline |
GM-Tg-cang-MP1614-Ab-1/ GM-Tg-cang-MP1614-Ab-2 | Anti-Canine SLC39A11 monoclonal antibody | Canine |
GM-Tg-bovg-MP1614-Ab-1/ GM-Tg-bovg-MP1614-Ab-2 | Anti-Bovine SLC39A11 monoclonal antibody | Bovine |
GM-Tg-equg-MP1614-Ab-1/ GM-Tg-equg-MP1614-Ab-2 | Anti-Equine SLC39A11 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1614-Ab-1/ GM-Tg-hg-MP1614-Ab-2; GM-Tg-rg-MP1614-Ab-1/ GM-Tg-rg-MP1614-Ab-2; GM-Tg-mg-MP1614-Ab-1/ GM-Tg-mg-MP1614-Ab-2; GM-Tg-cynog-MP1614-Ab-1/ GM-Tg-cynog-MP1614-Ab-2; GM-Tg-felg-MP1614-Ab-1/ GM-Tg-felg-MP1614-Ab-2; GM-Tg-cang-MP1614-Ab-1/ GM-Tg-cang-MP1614-Ab-2; GM-Tg-bovg-MP1614-Ab-1/ GM-Tg-bovg-MP1614-Ab-2; GM-Tg-equg-MP1614-Ab-1/ GM-Tg-equg-MP1614-Ab-2 |
Products Name | Anti-SLC39A11 monoclonal antibody |
Format | mab |
Target Name | SLC39A11 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SLC39A11 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species S39AB/ SLC39A11/ C17orf26 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLPm001364 | mouse Slc39a11 Lentivirus plasmid |
ORF Viral Vector | pGMLPm001365 | mouse Slc39a11 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001364 | mouse Slc39a11 Lentivirus particle |
ORF Viral Vector | vGMLPm001365 | mouse Slc39a11 Lentivirus particle |
Target information
Target ID | GM-MP1614 |
Target Name | SLC39A11 |
Gene ID | 201266,69806,287796,695406,106559224,101090564,615681,100052800 |
Gene Symbol and Synonyms | 1810074D23Rik,C17orf26,SLC39A11,ZIP-11,ZIP11 |
Uniprot Accession | Q8N1S5,Q6P6S2,Q2YDD4 |
Uniprot Entry Name | S39AB_HUMAN,S39AB_RAT,S39AB_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000133195 |
Target Classification | N/A |
The target: SLC39A11, gene name: SLC39A11, also named as C17orf26, ZIP-11, ZIP11. Predicted to enable zinc ion transmembrane transporter activity. Predicted to be involved in zinc ion transmembrane transport. Predicted to be located in Golgi apparatus; nucleus; and plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.